Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle
Synlogic Inc. Common Stock | FinOracle

Synlogic Inc. Common Stock

Symbol: (NASDAQ:SYBX)

Synlogic Inc. is a biotechnology company that focuses on developing synthetic biotic medicines. Their innovative approach uses genetically engineered microbes to treat a range of diseases, such as metabolic disorders and cancer. With their cutting-edge technology and promising pipeline, Synlogic is poised to make a significant impact in the field of biopharmaceuticals.

Latest News

No Content Available

Welcome Back!

Login to your account below

Create New Account!

Fill the forms bellow to register

Retrieve your password

Please enter your username or email address to reset your password.

Home
Trends
Premium
Favorite
Account
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?